Search
Close this search box.

RNA Insights

Dive into our team's latest insights about life sciences deal making, transaction support and value creation.

Thomas Foster Joins RNA Advisors as Managing Principal

RNA Advisors, LLC, a leading valuation and strategic... [read more]

Fairness Opinions: Why Expertise Matters Now More Than Ever in Life Sciences and Healthcare

Since 2015, RNA Advisors has provided valuation, transactional... [read more]

Scott Winder joins RNA to expand its Life Science Tax and Financial Reporting Valuation Group

RNA Advisors, LLC, a leading valuation and strategic... [read more]

Client Success: Healthcare Transaction Support to Assess Value from Different Perspectives

By Jeff Williamson THE SITUATION: A healthcare company... [read more]

Client Success: Mandatory Adoption of ASC 842 – Incremental Borrowing Rate Analysis for Private Biotech

By Jeff Suchocki, CFA The Situation: Adoption of... [read more]

Client Success: Strategic Extension for Revenue-Stage Medtech Company

By Jeff Williamson THE SITUATION: A medical device... [read more]

Client Success: Navigating Strategic Investment in Healthcare Technology

THE PROBLEM: A healthcare technology company that sells... [read more]

RNA Proudly Welcomes Jeff Williamson

Jeff Williamson has joined the RNA Advisors growing... [read more]

Client Success: Incremental Borrowing Rate Analysis for Publicly Traded, Clinical Stage Biotech

THE PROBLEM:  A publicly traded clinical stage biotech... [read more]

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.